Provider Alert! Updates to the Preferred Drug List (PDL) for Androgenic agents, Macrolides-Ketolides, Antiviral, Bronchodilator and Growth Hormone drug classes
Date: November 8, 2023 Attention: All Providers Effective Date: October 31, 2023 Call to action: Texas Health and Human Services (HHSC) moved select medication(s) listed below to “preferred” status due to various drug shortages at this time. We are notifying providers more options to prescribe your members if they cannot obtain their current medication(s). A summary of the changes is included below. Impacted medications(s) Preferred medication Type of change Effective Date Androgel [B] Testosterone Gel (TOPICAL) [G] Generic now preferred October 16, 2023 Valcyte [B] Valganciclovir solution (ORAL) [G] Generic now preferred October 16, 2023 Nordotropin [B] Omnitrope*...
